title: Two cases of permanent indwelling catheter for long-term administration of intrapleural chemotherapy.
authors.affiliation: Servicio de Neumología, Hospital Royo Villanova, Zaragoza, España. Electronic address: javilazarosdr@gmail.com.
authors.forename: Javier
authors.initials: J
authors.lastname: Lázaro Sierra
authors.affiliation: Servicio de Hematología, Hospital Royo Villanova, Zaragoza, España.
authors.forename: Vicente
authors.initials: V
authors.lastname: Carrasco
authors.affiliation: Servicio de Neumología, Hospital La Fe, Valencia, España.
authors.forename: Enrique
authors.initials: E
authors.lastname: Cases
authors.affiliation: Servicio de Neumología, Hospital General de la Defensa, Zaragoza, España.
authors.forename: Cristina
authors.initials: C
authors.lastname: Gómez Gonzalez
mesh_terms: D000368:Aged; D000074322:Antineoplastic Agents, Immunological / Q000008:administration & dosage*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D000069286:Bortezomib / Q000008:administration & dosage; D002408:Catheters, Indwelling; D003907:Dexamethasone / Q000008:administration & dosage; D004322:Drainage / Q000379:methods; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D000077269:Lenalidomide; D016403:Lymphoma, Large B-Cell, Diffuse / Q000150:complications / Q000188:drug therapy*; D009101:Multiple Myeloma / Q000150:complications / Q000188:drug therapy*; D016066:Pleural Effusion, Malignant / Q000188:drug therapy* / Q000209:etiology; D000069283:Rituximab / Q000008:administration & dosage; D013792:Thalidomide / Q000008:administration & dosage / Q000031:analogs & derivatives; D000069258:Thoracentesis
chemical_list: D000074322:Antineoplastic Agents, Immunological; D000069283:Rituximab; D013792:Thalidomide; D000069286:Bortezomib; D003907:Dexamethasone; D000077269:Lenalidomide